Analyst Reco. Doximity, Inc.

Equities

DOCS

US26622P1075

Real-time Estimate Cboe BZX Other stock markets 10:12:30 2024-04-25 am EDT			5-day change	1st Jan Change
23.4 ^USD	-2.13%		-5.60%	-16.44%

Apr. 01	Doximity Business Under Pressure as Underlying Sales Falling, Jehoshaphat Research Says	MT
Mar. 15	JPMorgan Adjusts Price Target on Doximity to $25 From $22, Maintains Underweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target is $25	07:31am	MT
JPMorgan Adjusts Price Target on Doximity to $25 From $22, Maintains Underweight Rating	Mar. 15	MT
Leerink Partners Initiates Doximity at Market Perform Rating With $32 Price Target	Feb. 26	MT
Jefferies Raises Doximity's Price Target to $35 From $30, Buy Rating Kept	Feb. 12	MT
Wells Fargo Adjusts Price Target on Doximity to $27 From $25, Maintains Equalweight Rating	Feb. 09	MT
BofA Securities Upgrades Doximity to Neutral From Underperform, Adjusts Price Target to $29 From $21	Jan. 02	MT
Morgan Stanley Raises Price Target on Doximity to $25 From $21, Cites 'Solid Quarter,' Keeps Underweight Rating	Nov. 10	MT
North American Morning Briefing : Investors Weigh Higher-For-Longer Rates	Nov. 10	DJ
Wells Fargo Adjusts Doximity Price Target to $25 From $37, Maintains Equal Weight Rating	23-08-11	MT
Truist Securities Adjusts Price Target on Doximity to $28 From $33, Maintains Hold Rating	23-08-09	MT
Needham Downgrades Doximity to Hold From Buy	23-08-09	MT
Raymond James Adjusts Price Target on Doximity to $30 From $40, Keeps Outperform Rating	23-08-09	MT
Guggenheim Downgrades Doximity to Neutral From Buy	23-08-09	MT
Morgan Stanley Cuts Price Target on Doximity to $21 From $28, Notes Guidance 'Materially Below the Street,' Keeps Underperform Rating	23-08-09	MT
Piper Sandler Downgrades Doximity to Neutral From Overweight, Adjusts Price Target to $36 From $38	23-08-03	MT
Truist Securities Adjusts Price Target on Doximity to $33 From $36, Keeps Hold Rating	23-06-05	MT
Canaccord Genuity Adjusts Price Target on Doximity to $40 From $41, Maintains Buy Rating	23-05-17	MT
Evercore ISI Group Adjusts Price Target on Doximity to $32 From $33, Maintains In Line Rating	23-05-17	MT
Morgan Stanley Adjusts Price Target on Doximity to $28 From $29, Maintains Underweight Rating	23-05-17	MT
Wells Fargo Downgrades Doximity to Equal Weight From Overweight, Adjusts Price Target to $37 From $39	23-05-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Doximity, Inc.

Equities

DOCS

US26622P1075

Analyst Reco.

Filters